Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Lotte C. G. Hoegberg, Greene Shepherd, David M. Wood, Jami Johnson, Robert S. Hoffman, E. Martin Caravati, Wui Ling Chan, Silas W. Smith, Kent R. Olson & Sophie Gosselin. (2021) Systematic review on the use of activated charcoal for gastrointestinal decontamination following acute oral overdose. Clinical Toxicology 59:12, pages 1196-1227.
Read now
Read now
David O. Cooney. (1995) In Vitro Adsorption of Phenobarbital, Chlorpheniramine Maleate, and Theophylline by Four Commercially Available Activated Charcoal Suspensions. Journal of Toxicology: Clinical Toxicology 33:3, pages 213-217.
Read now
Read now
Fred Harchelroad, Eric Cottington & E. P. Krenzelok. (1989) Gastrointestinal transit times of a charcoal/sorbitol slurry in overdose patients. Journal of Toxicology: Clinical Toxicology 27:1-2, pages 91-99.
Read now
Read now
Kay A. Mereish & Rikki Solow. (1989) Interaction of Microcystin-LR with Superchar: Water Decontamination and Therapy. Journal of Toxicology: Clinical Toxicology 27:4-5, pages 271-280.
Read now
Read now
Cheryl D. Curd-Sneed, John G. Bordelon, K. Scott Parks & John J. Stewart. (1987) Effects of Activated Charcoal and Sorbitol on Sodium Pentobarbital Absorption in the Rat. Journal of Toxicology: Clinical Toxicology 25:7, pages 555-566.
Read now
Read now
Cheryl D. Curd-Sneed, K. Scott Parks, John G. Bordelon & John J. Stewart. (1987) In vitro Adsorption of Sodium Pentobarbital by Superchar, USP and Darco G-60 Activated Charcoals. Journal of Toxicology: Clinical Toxicology 25:1-2, pages 1-11.
Read now
Read now
Jan A. Cordonnier, Marc A. van den Heede & Aubin M. Heyndrickx. (1986) In vitro adsorption of tilidine HCL by activated charcoal. Journal of Toxicology: Clinical Toxicology 24:6, pages 503-517.
Read now
Read now
Douglas C. Chung, John E. Murphy & T. W. Taylor. (1982) In-Vivo Comparison of the Adsorption Capacity of “Superactive Charcoal” and Fructose with Activated Charcoal and Fructose. Journal of Toxicology: Clinical Toxicology 19:2, pages 219-224.
Read now
Read now
David O. Cooney & Robert P. Kane. (1980) “Superactive” Charcoal Adsorbs Drugs as Fast as Standard Antidotal Charcoal. Clinical Toxicology 16:1, pages 123-125.
Read now
Read now
E. E. McConnell, M. W. Harris & J. A. Moore. (1980) Studies on the Use of Activated Charcoal and Cholestyramine for Reducing the Body Burden of Polybrominated Biphenyls. Drug and Chemical Toxicology 3:3, pages 277-292.
Read now
Read now
Jan Medema. (1979) Comments on “A Superactive Charcoal for Antidotal Use in Poisonings”. Clinical Toxicology 14:2, pages 205-206.
Read now
Read now
Articles from other publishers (26)
Guillermo Burillo-Putze & Pere Munne Mas. (2010) Carbón activado en las intoxicaciones agudas: ¿está todo dicho?. Medicina Clínica 135:6, pages 260-262.
Crossref
Crossref
Kent R. Olson. (2010) Activated Charcoal for Acute Poisoning: One Toxicologist’s Journey. Journal of Medical Toxicology 6:2, pages 190-198.
Crossref
Crossref
James R. Roberts, Ed. J. Gracely & John M. Schoffstall. (2008) Advantage of High‐surface‐area Charcoal for Gastrointestinal Decontamination in a Human Acetaminophen Ingestion Model. Academic Emergency Medicine 4:3, pages 167-174.
Crossref
Crossref
Franz-Xaver Reichl, Göran Hunder, Bernhard Liebl, Burckhard Fichtl & Wolfgang Forth. (1995) Effect of DMPS and various adsorbents on the arsenic excretion in guinea-pigs after injection with As2O3. Archives of Toxicology 69:10, pages 712-717.
Crossref
Crossref
Jeanmarie Perrone, Robert S. Hoffman & Lewis R. Goldfrank. (1994) Special Considerations in Gastrointestinal Decontamination. Emergency Medicine Clinics of North America 12:2, pages 285-299.
Crossref
Crossref
Kaveh Ilkhanipour, Donald M. Yealy & Edward P. Krenzelok. (1993) Activated charcoal surface area and its role in multiple-dose charcoal therapy. The American Journal of Emergency Medicine 11:6, pages 583-585.
Crossref
Crossref
Gary M. Oderda. (2016) Gastrointestinal Decontamination. Journal of Pharmacy Practice 6:2, pages 48-56.
Crossref
Crossref
Arthur Karl McFarlandIIIIII & Peter A. Chyka. (2016) Selection of Activated Charcoal Products for the Treatment of Poisonings. Annals of Pharmacotherapy 27:3, pages 358-361.
Crossref
Crossref
P. Lheureux & R. Askenasi. (1992) Prévention de l'absorption digestive des toxiques : une réévaluation critique deuxième partie : utilisation du charbon activé et des laxatifs. Réanimation Urgences 1:6, pages 915-926.
Crossref
Crossref
Edward C DillonJrJr, John H Wilton, Jared C Barlow & William A Watson. (1989) Large surface area activated charcoal and the inhibition of aspirin absorption. Annals of Emergency Medicine 18:5, pages 547-552.
Crossref
Crossref
Joann Gren & Alan Woolf. (1989) Hypermagnesemia associated with catharsis in a salicylate-intoxicated patient with anorexia nervosa. Annals of Emergency Medicine 18:2, pages 200-203.
Crossref
Crossref
William R Weaver. (1988) Actual clinical settings and the use of activated charcoal. Annals of Emergency Medicine 17:6, pages 662-663.
Crossref
Crossref
Richard J Lambert, Barbara L Kindler & David J Schaeffer. (1988) The efficacy of superactivated charcoal in treating rats exposed to a lethal oral dose of potassium cyanide. Annals of Emergency Medicine 17:6, pages 595-598.
Crossref
Crossref
Pertti J. Neuvonen & Klaus T. Olkkola. (2012) Oral Activated Charcoal in the Treatment of Intoxications. Medical Toxicology 3:1, pages 33-58.
Crossref
Crossref
Edward P Krenzelok & Michael B Heller. (1987) Effectiveness of commercially available aqueous activated charcoal products. Annals of Emergency Medicine 16:12, pages 1340-1343.
Crossref
Crossref
Glenn W. Ginoza, Arthur A. Strauss, Melinda K. Iskra & Houchang D. Modanlou. (1987) Potential treatment of theophylline toxicity by high surface area activated charcoal. The Journal of Pediatrics 111:1, pages 140-142.
Crossref
Crossref
Jeffrey Jones, M.J. McMullen, James Dougherty & Louis Cannon. (1987) Repetitive doses of activated charcoal in the treatment of poisoning. The American Journal of Emergency Medicine 5:4, pages 305-311.
Crossref
Crossref
Peter K. Gessner & Mazen M. Hasan. (1987) Freundlich and Langmuir Isotherms as Models for the Adsorption of Toxicants on Activated Charcoal. Journal of Pharmaceutical Sciences 76:4, pages 319-327.
Crossref
Crossref
Brian G Katona, Earl G Siegel & Robert J CluxtonJrJr. (1987) The new black magic: Activated charcoal and new therapeutic uses. The Journal of Emergency Medicine 5:1, pages 9-18.
Crossref
Crossref
George C. RodgersJr.Jr. & Nancy J. Matyunas. (1986) Gastrointestinal Decontamination for Acute Poisoning. Pediatric Clinics of North America 33:2, pages 261-285.
Crossref
Crossref
Susan M. Pond. (2012) Role of Repeated Oral Doses of Activated Charcoal in Clinical Toxicology. Medical Toxicology 1:1, pages 3-11.
Crossref
Crossref
GLEN D. PARK, REYNOLD SPECTOR, MARK J. GOLDBERG, GEORGE F. JOHNSON, ROSS FELDMAN & CONNIE K. QUEE. (2013) Effect of the Surface Area of Activated Charcoal on Theophylline Clearance. The Journal of Clinical Pharmacology 24:7, pages 289-292.
Crossref
Crossref
O. A. Portnoi, V. G. Nikolaev, L. I. Fridman, A. L. Belkin, T. N. Postrelko, K. A. Pendrak, E. V. Eretskaya, M. S. Povzhitkova, E. A. Snezhkova & A. B. Ivanova. (1984) Investigation of the sorption of biologically active substances by activated carbon fibers. Pharmaceutical Chemistry Journal 18:3, pages 204-208.
Crossref
Crossref
Gary C. Cupit & Anthony R. Temple. (1984) Gastrointestinal Decontamination in the Management of the Poisoned Patient. Emergency Medicine Clinics of North America 2:1, pages 15-28.
Crossref
Crossref
P. J. Neuvonen & K. T. Olkkola. (1984) Effect of dose of charcoal on the absorption of disopyramide, indomethacin and trimethoprim by man. European Journal of Clinical Pharmacology 26:6, pages 761-767.
Crossref
Crossref
S. Dawling, S. Chand, R.A. Braithwaite & P. Crome. (2016) In Vitro and In Vivo Evaluation of Two Preparations of Activated Charcoal as Adsorbents of Aspirin. Human Toxicology 2:2, pages 211-216.
Crossref
Crossref